Predict your next investment

Inanovate company logo
SOFTWARE (NON-INTERNET/MOBILE) | Healthcare Software
inanovate.com

See what CB Insights has to offer

Founded Year

2010

Stage

Unattributed | Alive

Total Raised

$5.87M

Last Raised

$460K | 1 yr ago

Mosaic Score

+10 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About Inanovate

Inanovate has developed a technology for the detection and measurement of multiple proteins called Longitudinal Assay Screening (LAS). LAS has since been integrated into Inanovate's first product – The Bio-ID 400.

Inanovate Headquarter Location

2329 North Career Ave Suite 113

Sioux Falls, South Dakota, 57107,

United States

+1-605-679-6460

Latest Inanovate News

Here are the finalists for the diagnostics track of INVEST Pitch Perfect

Apr 7, 2021

MedCity News Here are the finalists for the diagnostics track of INVEST Pitch Perfect Finalists for the diagnostics track at INVEST Pitch Perfect include tests for upper respiratory infections, breast cancer screening, in vitro cellular immunoassays, dysphagia diagnostics, and neuroscience. Shares0 It’s been an exciting 12 months for the diagnostics sector given all the activity we have seen since Covid-19 became a worldwide pandemic. Finalists for the diagnostics track at INVEST Pitch Perfect embrace span biosensors, upper respiratory infections, breast cancer screening, in vitro cellular immunoassays, dysphagia diagnostics, and neuroscience. The INVEST Pitch Perfect  contest is part of our  INVEST conference April 19-23 , which will be hosted online due to Covid-19. It includes five tracks for startups: biopharma, medical devices, diagnostics, health IT and health services. Click here to see the rest of the agenda. Raised at least $1 million;  Raised a Series A round;  Have at least one qualified institutional investor or strategic investor Judges for the track include: Ryan Kole, Partner with VCapital Here are the finalists: EDP Biotech develops and commercializes convenient, cost-effective diagnostics which detect disease early. GRIP Molecular’s single-use biosensor and mobile app provides consumers highly accurate and comprehensive medical diagnostic information in minutes, anytime and anywhere. The patented, graphene-enabled solid-state electronic platform technology is easy to use and does not require chemical reagents or a separate reader. GRIP’s underlying technology can simultaneously detect the presence of infectious disease pathogens and characterize the host response, including the immune response, to enable information-enabled diagnosis and the rapid application of appropriate therapy. The first product will simultaneously provide diagnostic information for COVID-19, Influenza A/B and other common upper respiratory infections. Proof of concept has been completed and development is underway with initial product launch anticipated in 2023. Inanovate has developed a patented blood analysis system (the Bio-ID) that improves the cost, accessibility, and accuracy of diagnostic tests. The first application of the Bio-ID is a new blood test to be used as a supplement to mammography to help reduce false positive results in breast cancer screening. Approximately 10% of the 39 million screening mammograms performed annually in the US require follow-up testing to resolve the diagnosis, yet more than 95% of these are ‘false positives’ in which no cancer is detected. The economic cost of false-positive mammograms is ~$4 billion, and >1 million women are exposed to risks associated with subsequent diagnostics. Inanovate seeks to address this issue through a simple, inexpensive blood test, that will provide additional data on a patients cancer risk to help inform clinicians whether follow up procedures are necessary. Loop Diagnostics is a novel first-in-class in vitro cellular immunoassay that identifies sepsis after the first-hour of bloodstream infection. We have developed a patented method and kit (with disposable) to identify immune activity biomarkers, that is 3x more sensitive than the current biomarker competitor (PCT) and provides a 10x faster diagnosis than pathogen identification. Our biomarker appears after the first hour of infection, long before PCT can detect the presence of Sepsis. This will allow healthcare professionals to begin accurate treatment earlier – reducing the severity of the disease and decreasing the number of antibiotics or other drugs necessary for treatment. Patheous Health is building a Dysphagia Care-as-a-Service (CaasSD) business to improve access to feeding and swallow healthcare for senior care providers. Our diagnostic and therapeutic solutions impact patients that suffer from swallowing impairment and nutrition consumption in multiple care settings, including skilled nursing, home health, in-patient rehabilitation, assisted living and community dwelling adults. Patheous Health closed the Series A round in March 2020 and acquired the largest US provider of onsite dysphagia diagnostics. The acquisition provided immediate revenues and 375 senior care provider facility clients. We are building on our customer base, expanding our value-based service, and building a deep channel to introduce our Dysphagic Care-as-a-Service platform. Our team is composed of world-class experts in dysphagia research and care and supported by experienced executives that know how to build a clinical care business. Virtuleap unlocks neuroscience with virtual reality to help pharmaceutical companies accelerate the approval of drugs designed to treat cognitive illnesses like Alzheimer’s disease. Photo: Adam Taylor, Getty Images MedCity News MedCity News publishes a series of important, powerful conversations on the business of healthcare with the help of key partners and sponsors. Shares0 Topics

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Inanovate

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Inanovate in 1 CB Insights research brief, most recently on Aug 24, 2021.

Expert Collections containing Inanovate

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Inanovate is included in 1 Expert Collection, including Digital Health.

D

Digital Health

10,285 items

Companies using/incorporating digital tech into health, wellness, and life science offerings. Includes cos operating within the hc, consumer health, and life science industries + tech vendors catering to them. Excludes cos exclusively focused on fitness/sports & performance

Inanovate Patents

Inanovate has filed 6 patents.

The 3 most popular patent topics include:

  • Engine technology
  • Fluid dynamics
  • Gas compressors
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/22/2015

8/28/2018

Analytical chemistry, Molecular biology, Transcription factors, Mass spectrometry, Chromatography

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

1/22/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

8/28/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Analytical chemistry, Molecular biology, Transcription factors, Mass spectrometry, Chromatography

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Inanovate Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Inanovate Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.